Pregnancy characteristics and maternal risk of breast cancer

Epidemiology

Volumn 9, Issue 6, 1998, Pages 641-647

  Troisi, Rebecca ^a   Weiss, Helen A ^a   Hoover, Robert N ^a   Potischman, Nancy ^a   Swanson, Christine A ^a   Brogan, Donna R ^b   Coates, Ralph J ^c   Gammon, Marilie D ^d   Malone, Kathleen E ^e   Daling, Janet R ^e   Brinton, Louise A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Breast cancer; Gestational diabetes; Pregnancy; Toxemia; Twinning; Weight gain

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY TOXEMIA; PRIORITY JOURNAL; RISK ASSESSMENT; VOMITING; WEIGHT GAIN;

EID: 0031697073     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199811000-00014     Document Type: Article

References (27)

1. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
2. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis: a review. Breast Cancer Res Treat 1982;2: 5-73.
3. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 1994;3:353-364.
4. Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK. Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1995;4:437-440.
5. Thompson WD, Jacobson HI, Negrini B, Janerich DT. Hypertension, pregnancy, and risk of breast cancer. J Natl Cancer Inst 1989;81:1571-1574.
6. Jovanovic L, Landesman R, Saxena BB. Screening for twin pregnancy. Science 1977;198:738.
7. Crosignani PG, Nencioni T, Brambati B. Concentration of chorionic gonadotropin and chorionic somatomammotrophin in maternal serum, amniotic fluid and cord blood serum at term. J Obstet Gynaecol Br Commonw 1972;79:122-126.
8. Depue RH, Bernstein L, Ross RK, Judd HL, Henderson BE. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol 1987;156: 1137-1141.
9. Masson GM, Anthony F, Chau E. Serum chorionic gonadotropin (hCG), schwangerschaftsprotein 1 (SP1), progesterone and oestradiol levels in patients with nausea and vomiting in early pregnancy. Br J Obstet Gynecol 1985;92:211-215.
10. Mori M, Amino N, Tamaki H, Miyai K, Tanizawa O. Morning sickness and thyroid function in normal pregnancy. Obstet Gynecol 1988;72:355-359.
11. Soules MR, Hughes CL, Garcia JA, Livengood CH, Prystowsky MR, Alexander E. Nausea and vomiting of pregnancy: role of human chorionic gonadotropin and 17-hydroxyprogesterone. Obstet Gynecol 1980;55:696-700.
12. Wald N, Barker S, Peto R, Brock DJH, Bonnar J. Maternal serum alphafetoprotein levels in multiple pregnancy. BMJ 1975;1:651-652.
13. Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol 1996;88:816-822.
14. Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, Stanford JL, Coates RJ, Gammon MD, Hanson L, Hoover RN. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995;87:827-835.
15. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978;73:40-46.
16. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol. 1. The Analysis of Case-Control Studies. IARC Scientific Pub. No. 32. Lyon: International Agency for Research on Cancer, 1980.
17. Polednak AP, Janerich DT. Characteristics of first pregnancy in relation to early breast cancer: a case-control study. J Reprod Med 1983;28:314-318.
18. Wyshak G, Honeyman MS, Flannery JT, Beck AS. Cancer in mothers of dizygotic twins. J Natl Cancer Inst 1983;70:593-599.
19. Nasca PC, Weinstein A, Baptiste M, Mahoney M. The relation between multiple births and maternal risk of breast cancer. Am J Epidemiol 1992; 136:1316-1320.
20. Trentham Dietz A, Newcomb PA, Storer BE, Longnecker MP, Mittendorf R. Multiple births and risk of breast cancer. Int J Cancer 1995;62:162-164.
21. Jacobson HI, Thompson WD, Janerich DT. Multiple births and maternal risk of breast cancer. Am J Epidemiol 1989;129:865-873.
22. Lambe M, Hsieh C-c, Tsaih S-w, Ekbom A, Adami H-O, Trichopoulos D. Maternal risk of breast cancer following multiple births: a nationwide study in Sweden. Cancer Causes Control 1996;7:533-538.
23. Hsieh C-c, Goldman M, Pavia M, Ekbom A, Petridou E, Adami H-O, Trichopoulos D. Breast cancer risk in mothers of multiple births. Int J Cancer 1993;54:81-84.
24. Janerich DT, Stark AD, Glebatis DM. Sex of first child as a prognostic factor for breast cancer in young women. Am J Epidemiol 1980;111:297-300.
25. Enger SM, Ross RK, Henderson B, Bernstein L. Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer 1997;76:118-123.
26. Janerich DT, Hoff MB. Evidence for a crossover in breast cancer risk factors. Am J Epidemiol 1982;116:737-742.
27. Steier JA, Myking OL, Ulstein M. Human chorionic gonadotropin in cord blood and peripheral maternal blood in singleton and twin pregnancies at delivery. Acta Obstet Gynecol Scand 1989;68:689-692.